Cardiac Linear and Torsional Contractility Measurements With a New Technology: Multi Dimensional Kineticardiography
- Conditions
- Healthy
- Interventions
- Device: Cardiac assessment repeatability with Kino-cardiographDevice: Cardiac contractility assessments with Kino-cardiograph
- Registration Number
- NCT03107351
- Lead Sponsor
- Erasme University Hospital
- Brief Summary
This study aims to validate the possibility to track cardiac contractility changes with a new technology called 'Heart Kinetic' (HK). HK measurements will be realized and compared echocardiography.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 34
- Adult between 18 and 50 years old.
- Healthy without medical cardiac conditions history.
- Non smoker.
- Does not take any drugs or medications.
- Does not participate in other clinical study or trial.
- BMI (Body Mass Index) in between 20 and 25 kg/m2.
- Being younger than 18 or older than 50 years old.
- Having had previous cardiac conditions or present disease.
- Being a regular smoker.
- Taking any drugs or medications
- Taking part in another clinical study or trial.
- BMI (Body Mass Index) lower than 20 or higher than 25 kg/m2.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description repeatability measures Cardiac assessment repeatability with Kino-cardiograph In this arm, healthy subjects will undergo repeated measures at different times of the day. Contractility changes measures Cardiac contractility assessments with Kino-cardiograph In this arm, healthy subjects will have their cardiac contractility increased in a controlled way and assessed with both HK and echocardiography.
- Primary Outcome Measures
Name Time Method HK reproducibility validation day 1 Validate the reproducibility of HK measurements in a clinical environment.
Cardiac contractility tracking with HK day 1 Proof that the HK technology can track physiological cardiac changes while comparing with gold standard echocardiography and inducing a cardiac contractility change with dobutamine infusion.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hôpital Erasme
🇧🇪Brussels, Anderlecht, Belgium